Cover Image
Market Research Report

North America Vascular Guidewires Market Forecast 2019-2027

Published by Inkwood Research Product code 904360
Published Content info 80 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Vascular Guidewires Market Forecast 2019-2027
Published: August 7, 2019 Content info: 80 Pages
Description

KEY FINDINGS

The North America vascular guidewires market accounted for a significant share of XX% in 2018 and is expected to grow with the 4.88% CAGR during the estimated period of 2019-2027. The market growth in the region is influenced by the trend of rising cases of chronic diseases, rapid innovation in medical devices along with favorable government policies.

MARKET INSIGHTS

The analysis of North America vascular guidewires market is studied over economies like the United States and Canada. In North American countries, the sedentary lifestyle and unhealthy food habits of people together with geriatric populace results in rising incidences of cardiovascular diseases. As a result of this, the demand for minimally invasive vascular procedures and devices increases, which influence the vascular guidewires market. Further, the favorable reimbursements framework in various countries drives the vascular guidewires market in the region. Also, due to the rising awareness among people about the vascular disorders and available treatment options, the vascular guidewires market is expected to witness mounting growth in upcoming years.

COMPETITIVE INSIGHTS

The prominent players in the market are, namely Abbott, GaltNeedleTech, Boston Scientific Corporation, Edward Lifesciences, Cook Medical LLC, Koninklijke Philips N.V., Becton Dickinson and Company, Cardinal Health Inc., B Braun Melsungen AG, and Biotronik Se & Co. KG., among others. These players focus on various strategic initiatives such as mergers & acquisitions, collaborations, and new products development to maintain a stronghold in the market.

Table of Contents
Product Code: 26226

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CORONARY GUIDEWIRES ARE THE MAJORLY USED APPLICATION
    • 3.2.2. HYDROPHOBIC COATING IS THE FASTEST GROWING COATED TYPE
    • 3.2.3. HOSPITALS ARE THE HIGHEST REVENUE GENERATING END USERS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN PREVALENCE OF CHRONIC DISEASES
    • 4.2.2. INCREASING DEMAND FOR MI PROCEDURES
    • 4.2.3. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS
    • 4.2.4. PREVAILING HIGH UNMET MEDICAL NEEDS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. RISKS ASSOCIATED WITH THE USE OF GUIDEWIRES
    • 4.3.2. UNFAVORABLE PREFERENCE FOR DRUGS
    • 4.3.3. ISSUE IN LOST GUIDEWIRE RETRIEVAL
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. TECHNOLOGICAL ADVANCEMENTS
    • 4.4.2. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. COMPLEXITIES ASSOCIATED IN THE MANUFACTURING OF VASCULAR GUIDEWIRES
    • 4.5.2. PRICING COUPLED WITH PAUCITY OF PRODUCT DIFFERENTIATION

5. MARKET BY APPLICATION

  • 5.1. CORONARY GUIDEWIRES
  • 5.2. PERIPHERAL GUIDEWIRES
  • 5.3. UROLOGICAL GUIDEWIRES
  • 5.4. NEUROVASCULAR GUIDEWIRES

6. MARKET BY COATING TYPE

  • 6.1. COATED
  • 6.2. NON-COATED

7. MARKET BY END USER

  • 7.1. HOSPITALS
  • 7.2. AMBULATORY SURGICAL CENTERS

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 8.1.3. BARGAINING POWER OF BUYER
    • 8.1.4. BARGAINING POWER OF SUPPLIER
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. VALUE CHAIN ANALYSIS
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. SUPPLY CHAIN ANALYSIS
  • 8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ABBOTT
    • 10.2.2. B BRAUN MELSUNGEN AG
    • 10.2.3. BECTON DICKINSON AND COMPANY
    • 10.2.4. BIOTRONIK SE & CO. KG
    • 10.2.5. BOSTON SCIENTIFIC CORPORATION
    • 10.2.6. CARDINAL HEALTH INC.
    • 10.2.7. COOK MEDICAL LLC
    • 10.2.8. EDWARD LIFESCIENCES
    • 10.2.9. GALTNEEDLETECH
    • 10.2.10. KONINKLIJKE PHILIPS N.V.
    • 10.2.11. MEDTRONIC
    • 10.2.12. MERIT MEDICAL SYSTEMS
    • 10.2.13. OLYMPUS CORPORATION
    • 10.2.14. TERUMO

LIST OF TABLES

  • TABLE 1 NORTH AMERICA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
  • TABLE 3 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 4 NORTH AMERICA CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 5 NORTH AMERICA PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 6 NORTH AMERICA UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 7 NORTH AMERICA NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 8 NORTH AMERICA COATED MARKET 2019-2027 ($ MILLION)
  • TABLE 9 NORTH AMERICA NON-COATED MARKET 2019-2027 ($ MILLION)
  • TABLE 10 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 11 NORTH AMERICA HOSPITALS MARKET 2019-2027 ($ MILLION)
  • TABLE 12 NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
  • TABLE 13 NORTH AMERICA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 14 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 15 THE UNITED STATES VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 16 THE UNITED STATES VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 17 THE UNITED STATES VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 18 CANADA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 19 CANADA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 20 CANADA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 INCIDENCE OF CHRONIC DISEASE IN THE UNITED STATES 2018
  • FIGURE 3 NORTH AMERICA VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 4 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 5 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 6 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 7 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 8 NORTH AMERICA VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
  • FIGURE 9 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
  • FIGURE 10 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
  • FIGURE 11 NORTH AMERICA VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 12 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
  • FIGURE 13 NORTH AMERICA VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 14 PORTER'S FIVE FORCE MODEL
  • FIGURE 15 THE UNITED STATES VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 16 CANADA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 17 VASCULAR GUIDEWIRES COMPANY SHARE ANALYSIS 2018 (%)
Back to Top